Japan Hospice Holdings Inc.(JP:7061)
Â¥337.00-20.00 (-5.60%)
JP:7061
Japan Hospice Holdings Inc. financials statements
Â¥337.00
At close:-20.00 (-5.60%)
Want to see JP:7061 full AI Analyst Report?
Japan Hospice Holdings Inc. (7061) Ratios
0 Followers
Japan Hospice Holdings Inc. Ratios
JP:7061's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:7061's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.34 | 1.27 | 1.91 | 1.75 | 1.06 |
| Quick Ratio | 1.34 | 1.27 | 1.91 | 1.75 | 1.06 |
| Cash Ratio | 0.59 | 0.51 | 1.00 | 0.89 | 0.52 |
| Solvency Ratio | 0.06 | 0.08 | 0.09 | 0.08 | 0.06 |
| Operating Cash Flow Ratio | 0.31 | 0.28 | 0.60 | 0.52 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 0.62 | 0.59 | 2.60 | 1.70 | 0.42 |
| Net Current Asset Value | ¥ -10.69B | ¥ -11.08B | ¥ -8.87B | ¥ -6.47B | ¥ -5.53B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.70 | 0.72 | 0.72 | 0.71 | 0.73 |
| Debt-to-Equity Ratio | 3.58 | 3.83 | 4.05 | 4.02 | 4.34 |
| Debt-to-Capital Ratio | 0.78 | 0.79 | 0.80 | 0.80 | 0.81 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.48 | 0.47 | 0.49 | 0.52 |
| Financial Leverage Ratio | 5.15 | 5.31 | 5.63 | 5.70 | 5.96 |
| Debt Service Coverage Ratio | 0.54 | 0.79 | 1.84 | 1.38 | 0.51 |
| Interest Coverage Ratio | 1.84 | 2.98 | 3.66 | 3.39 | 2.91 |
| Debt to Market Cap | 0.52 | 0.40 | 0.16 | 0.12 | 0.15 |
| Interest Debt Per Share | 1623.56 | 1659.97 | 1398.60 | 1044.61 | 865.27 |
| Net Debt to EBITDA | 7.80 | 6.41 | 5.03 | 4.69 | 6.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 12.99% | 17.43% | 19.48% | 20.03% | 18.59% |
| EBIT Margin | 5.99% | 10.62% | 13.97% | 13.52% | 10.36% |
| EBITDA Margin | 10.11% | 15.01% | 18.14% | 17.78% | 14.15% |
| Operating Profit Margin | 5.99% | 10.62% | 13.00% | 12.15% | 9.94% |
| Pretax Profit Margin | 3.91% | 8.32% | 10.42% | 9.94% | 6.94% |
| Net Profit Margin | 1.96% | 5.28% | 6.91% | 5.76% | 4.00% |
| Continuous Operations Profit Margin | 1.96% | 5.28% | 6.91% | 6.06% | 4.00% |
| Net Income Per EBT | 50.14% | 63.45% | 66.31% | 57.98% | 57.68% |
| EBT Per EBIT | 65.30% | 78.33% | 80.11% | 81.76% | 69.79% |
| Return on Assets (ROA) | 1.47% | 3.49% | 4.50% | 3.97% | 2.63% |
| Return on Equity (ROE) | 7.56% | 18.56% | 25.33% | 22.62% | 15.68% |
| Return on Capital Employed (ROCE) | 5.47% | 8.40% | 9.67% | 9.83% | 8.34% |
| Return on Invested Capital (ROIC) | 2.48% | 4.82% | 6.13% | 5.63% | 4.12% |
| Return on Tangible Assets | 1.50% | 3.57% | 4.63% | 4.15% | 2.77% |
| Earnings Yield | 2.95% | 5.61% | 3.75% | 2.20% | 1.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.20 | 6.22 | 6.15 | 5.80 | 6.26 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 4900.19 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.11 | 0.92 | 0.97 | 1.08 | 0.99 |
| Asset Turnover | 0.75 | 0.66 | 0.65 | 0.69 | 0.66 |
| Working Capital Turnover Ratio | 14.58 | 9.64 | 6.64 | 11.54 | 13.63 |
| Cash Conversion Cycle | 58.86 | 58.67 | 59.37 | 62.95 | 58.24 |
| Days of Sales Outstanding | 58.86 | 58.67 | 59.37 | 62.95 | 58.32 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
| Operating Cycle | 58.86 | 58.67 | 59.37 | 62.95 | 58.32 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 124.45 | 101.86 | 140.61 | 109.02 | 58.75 |
| Free Cash Flow Per Share | -157.42 | -276.39 | -107.62 | 42.52 | -181.82 |
| Dividend Paid and CapEx Coverage Ratio | 0.42 | 0.26 | 0.57 | 1.64 | 0.24 |
| Capital Expenditure Coverage Ratio | 0.44 | 0.27 | 0.57 | 1.64 | 0.24 |
| Operating Cash Flow Coverage Ratio | 0.08 | 0.06 | 0.10 | 0.11 | 0.07 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.07 | 0.11 | 0.11 | 0.08 |
| Free Cash Flow Yield | -14.06% | -19.88% | -4.75% | 1.65% | -7.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.86 | 17.85 | 26.69 | 45.55 | 76.23 |
| Price-to-Sales (P/S) Ratio | 0.66 | 0.94 | 1.84 | 2.62 | 3.05 |
| Price-to-Book (P/B) Ratio | 2.56 | 3.31 | 6.76 | 10.30 | 11.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.11 | -5.03 | -21.04 | 60.78 | -12.70 |
| Price-to-Operating Cash Flow Ratio | 9.00 | 13.65 | 16.10 | 23.70 | 39.30 |
| Price-to-Earnings Growth (PEG) Ratio | -0.59 | -2.18 | 0.54 | 0.52 | 0.62 |
| Enterprise Value Multiple | 14.36 | 12.69 | 15.20 | 19.44 | 28.16 |
| Enterprise Value | 20.58B | 23.07B | 27.21B | 27.29B | 23.99B |
| EV to EBITDA | 14.36 | 12.69 | 15.20 | 19.44 | 28.16 |
| EV to Sales | 1.45 | 1.90 | 2.76 | 3.46 | 3.99 |
| EV to Free Cash Flow | -15.56 | -10.17 | -31.45 | 80.09 | -16.60 |
| EV to Operating Cash Flow | 19.68 | 27.60 | 24.07 | 31.23 | 51.37 |
| Tangible Book Value Per Share | 390.94 | 372.57 | 280.06 | 192.80 | 135.12 |
| Shareholders’ Equity Per Share | 437.56 | 420.07 | 334.89 | 250.84 | 193.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.50 | 0.37 | 0.34 | 0.39 | 0.42 |
| Revenue Per Share | 1685.69 | 1476.57 | 1227.90 | 984.94 | 757.12 |
| Net Income Per Share | 33.08 | 77.95 | 84.82 | 56.73 | 30.29 |
| Tax Burden | 0.50 | 0.63 | 0.66 | 0.58 | 0.58 |
| Interest Burden | 0.65 | 0.78 | 0.75 | 0.73 | 0.67 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.76 | 1.31 | 1.66 | 1.92 | 1.12 |
Currency in JPY

